Lisa Collins is CEO and Co-Founder of Innomas Clinical Research with more than 25 years of global experience in clinical operations, program management, and drug development.

She has led clinical programs across North America, Europe, Asia, the Middle East, Africa, and Australia, supporting pharmaceutical companies, biotechnology organizations, CROs, and research institutions.

Her expertise includes risk-based quality management (RBQM), risk-based monitoring (RBM), clinical operations leadership, inspection readiness, site management, and operational strategy.

Lisa helps organizations strengthen trial execution, participant protection, and data reliability while expanding access to high-quality clinical research across Africa.

Innocent Clement is Co-Founder and Chief Medical Officer of Innomas Clinical Research. He is a physician and healthcare entrepreneur with experience spanning clinical research, digital health, patient engagement, and healthcare innovation.

He brings a clinical perspective to Innomas' work, supporting the organization's commitment to participant protection, ethical research conduct, and medically informed trial execution.

Innocent's experience across healthcare delivery and clinical development helps strengthen Innomas' ability to support sponsors, investigators, and healthcare organizations conducting research across Africa and globally.

Leslie Sam is Chief Quality Officer of Innomas Clinical Research and Founder of Leslie Sam & Associates LLC. With more than 25 years of biopharmaceutical industry experience, she helps organizations strengthen quality systems, regulatory compliance, and risk-based oversight.

Her expertise includes RBQM, Quality by Design, inspection readiness, vendor oversight, clinical quality systems, and evolving ICH E6(R3) expectations. She supports pharmaceutical, biotechnology, and CRO organizations in building scalable quality approaches aligned with global expectations.

Leslie is an industry educator, speaker, and certified Lean Six Sigma Black Belt known for translating complex quality concepts into practical strategies that improve participant protection, data reliability, and study execution.

Cosmas Collins is Head of Clinical Data Management & Biometrics at Innomas Clinical Research, bringing more than 20 years of experience supporting global clinical development programs.

He has led data management and biometrics deliverables across multinational clinical trials, collaborating with teams throughout North America, Europe, Asia, and Africa.

His expertise includes clinical data management, database oversight, data quality review, vendor management, and the delivery of reliable, inspection-ready clinical trial data.

At Innomas, Cosmas helps organizations strengthen data quality and study execution through accurate, compliant, and decision-grade clinical data.